Medrx Co.,Ltd.

4586

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-07FY2026 Q2

Revenue

1.2100M JPY

YoY +167.4%

Operating Income

-5.4100M JPY

YoY +10.7%

Net Income

-8.6100M JPY

YoY +37.6%

EPS

-9.3JPY

YoY +27.7%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

2.6億円

-84.4百万円

-4.3億円

-7.7億円

-11.1億円

Rev: 8.3百万円Op: -10.6億円NI: -10.6億円

Rev: 59.5百万円Op: -11億円NI: -11.1億円

Rev: 29.5百万円Op: -9.3億円NI: -9.3億円

Rev: 2.6億円Op: -7.9億円NI: -8.1億円

Rev: 1.3億円Op: -9.4億円NI: -9.4億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income45.8%

Revenue Progress11M

Revenue Forecast3.900M

Net Income Progress-5.500M

Net Income Forecast-1200M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan